Among the affected pathways is the PI3K-AKT, which regulates inflammatory cytokines through NF-κβ.[37, 38] Treatment resistance in breast cancer is enhanced by activation of the NF-κβ pathway by inflammatory. The gene discussed is NFKB1; the disease is breast carcinoma.